Telomir Pharmaceuticals, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TELO and other ETFs, options, and stocks.About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ.
TELO Key Statistics
Stock Snapshot
As of today, Telomir Pharmaceuticals, Inc.(TELO) shares are valued at $0.75. The company's market cap stands at 52.49M, with a P/E ratio of -0.78.
On 2026-11-08, Telomir Pharmaceuticals, Inc.(TELO) stock traded between a low of $0.69 and a high of $0.82. Shares are currently priced at $0.75, which is +8.2% above the low and -8.5% below the high.
Telomir Pharmaceuticals, Inc.(TELO) shares are trading with a volume of 154.86K, against a daily average of 103.12K.
In the last year, Telomir Pharmaceuticals, Inc.(TELO) shares hit a 52-week high of $1.58 and a 52-week low of $0.69.
In the last year, Telomir Pharmaceuticals, Inc.(TELO) shares hit a 52-week high of $1.58 and a 52-week low of $0.69.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.